Evidence map›Paper›PMID 27223265›Full record

ArticleOrganic & biomolecular chemistry2016

Selective inhibition of p97 by chlorinated analogues of dehydrocurvularin.

Joseph Tillotson, Bharat P Bashyal, MinJin Kang, Taoda Shi, Fabian De La Cruz, A A Leslie Gunatilaka, Eli Chapman

Open access · greenAbstract read
In one paragraph

Article in Organic & biomolecular chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. The AAA+ ATPase p97, a cellular multitool.The Biochemical journal · 2017
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Joseph TillotsonCollege of Pharmacy, Department of Pharmacology and Toxicology, The University of Arizona, Tucson, Arizona 85721, USA. chapman@pharmacy.arizona.edu.
Bharat P Bashyal
MinJin Kang
Taoda Shi
Fabian De La Cruz
A A Leslie Gunatilaka
Eli Chapman
University of Arizona · US

Funding

SOUTHWEST ENVIRONMENTAL HEALTH SCIENCES CENTERP30ES006694 · NIEHS · UNIVERSITY OF ARIZONA · PI DEAN BILLHEIMER · 1994 to 2026
$36.7M
Training in Environmental Toxicology of Human DiseaseT32ES007091 · NIEHS · UNIVERSITY OF ARIZONA · PI Nathan J Cherrington · 1985 to 2026
$10.7M
Anticancer Agents from Plant- and Lichen-Associated Fungi of the Sonoran DesertR01CA090265 · NCI · UNIVERSITY OF ARIZONA · PI GUNATILAKA, LESLIE · 2002 to 2013
$2.2M
Stress response, p97, and Nrf2 in arsenic-mediated toxicityR01ES023758 · NIEHS · UNIVERSITY OF ARIZONA · PI CHAPMAN, ELI, ZHANG, DONNA D · 2014 to 2018
$1.6M
NCI NIH HHS R01 CA090265NIEHS NIH HHS P30 ES006694NIEHS NIH HHS R01 ES023758NIEHS NIH HHS T32 ES007091
6 · The paper itself

Abstract

The ATPase p97 is a ubiquitin targeted segregase that uses the energy of ATP binding and hydrolysis to extract ubiquitylated substrates from biological membranes, from other proteins, or from protein complexes to carry out myriad tasks in eukaryotes. Increased p97 activity has been linked to a poor prognosis in cancer patients, making p97 an anti-neoplastic target. In the present study, we show that dehydrocurvularin (DHC) and its chlorinated variants are covalent inhibitors of p97, interfering with its ATPase activity. Interestingly, cellular studies revealed both DHC and its monochloro analogue interfere with both the proteasome and p97, whereas its dichloro analogue showed p97 specificity.

Indexed as

HalogenationAdenosine TriphosphatasesDrug Evaluation, PreclinicalEnzyme InhibitorsNuclear ProteinsSubstrate SpecificityZearalenoneAdenosine TriphosphatasesdehydrocurvularinEnzyme InhibitorsNuclear Proteinsp97 ATPaseZearalenone

Identifiers

PMID27223265
PMCPMC5466822
OpenAlexW2408495424

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.